Table of contents for Asthma and copd : basic mechanisms and clinical management / edited by Peter J. Barnes ... [et al.].


Bibliographic record and links to related information available from the Library of Congress catalog. Note: Electronic data is machine generated. May be incomplete or contain other coding.


Counter




Foreword, ix                                        10 Macrophages, 99
G.B. Toews
Contributors, xi
Preface, xxi                                        11 Eosinophils, 111
W.B. Davis
Dedication, xxiii
12 Lymphocytes, 119
Part I: Definitions, Epidemiology, and Genetics         C. Agostini, M. Saetta, G. Semenzato
of Asthma and COPD
13 Neutrophils, 131
1 Definitions, 3                                           E.M. Drost, W MacNee
A.S. Buist
14 Fibroblasts, 139
2 Epidemiology, 7                                          R.J. McAnulty, G.J. Laurent
D.L. DeMeo, S. T Weiss
15 Epithelial Cells, 145
3 Natural History, 19                                      J.R. Spurzem, S.I. Rennard
ED. Martinez
16 Mucus and Mucin-Secreting Cells, 155
4 Genetics, 29                                             P-R. Burgel, J.A. Nadel
J. Gerritsen, M.Fiejen, D.S. Postma
17 Airway Smooth Muscle, 165
I Amrani, V.P Krymskaya, A.L. Lazaar,
Part II: Physiology and Pathology of Asthma             R.A. Panettieri
and COPD
18 Tracheobronchial Circulation, 177
5 Pulmonary Physiology, 43                                 G. Horvath, A.Wanner
G. Horvath, A. Wanner
N.B. Pride
19 Pulmonary Vessels, 183
6 Airway Pathology, 57                                     N.E Voelkel, R.M. Tuder
J. C. Hogg
20 Plasma Exudation, 195
7 Airway Remodeling, 67                                   C. G.A. Persson, J.S. Erjefalt, L. Uller, M. Andersson,
R.A. O'Donnell, D.E. Davies, S. T Holgate               L. Grieff
8 Animal Models, 79                                    21 Cell Adhesion Molecules, 203
S.A. Shore
~~S.~A. Shore                          A.L. Lazaar, S.M. Albelda
Part III: Inflammatory Cells and Extracellular      22 Extracellular Matrix, 211
Matrix                                                  M. Godfrey
9 Mast Cells and Basophils, 91
G.H. Caughey



Part IV: Inflammatory Mediators and Pathways       39 Infections, 407
S. Message, S. Johnston
23 Prostanoids, 221
PM. O'Byrne                                        40 Exercise as aTrigger, 421
S. Godfrey
24 Leukotrienes, 227
J.M. Drazen                                        41 Atmospheric Pollutants, 431
J. Ayres
25 Kinins, 237
D. Proud                                           42 Drugs, 439
J. Gibson
26 Reactive Oxygen Species, 243
I. Rhaman, WMacNee                                     Part VII: Clinical Assessment of Asthma and
COPD
27 Chemokines, 255
J.E. Pease, TJ. Williams                           43 Diagnosis, 447
M. Romagnoli, L. Richeldi, L.M. Fabbri
28 Cytokines, 261
K.E Chung                                          44 Non-invasive Assessment of Airway Inflammation, 457
S. Kharitonov
29 Matrix Degrading Proteinases, 273
S.D. Shapiro, E.J. Campbell                        45 Imaging, 465
30 Growth Factors, 283
M. Kolb, Z. Xing, J. Gauldie                       46 Assessment of Disability, 481
1P. WJones
31 Other Mediators of Airway Disease, 291
P.J. Barnes
Part VIII: Therapies for Asthma and COPD
32 Nitric Oxide, 307
A. Deykin, S.A.Kharatinov                          47 AllergenAvoidance, 489
A. Custovic, A. Woodcock
33 Transcription Factors, 315
I.M. Adcock, G Caramori                            48 Smoking Cessation, 509
A.W. Molyneux,J. Britton
34 Neural and Humoral Control, 323
P.7. Barnes, N.C. Thomson                          49 P3-adrenoceptor Agonists, 521
L P Hall
Part V: Pathogenic Mechanisms in Asthma and        50 Anticholinergic Bronchodilators, 527
COPD                                                   S.E. Cattapan, N.J. Gross
35 Pathophysiology of Asthma, 343                      51 Theophylline, 535
P.J. Barnes, J.M. Drazen                               PJ. Barnes
36 Pathogenesis of COPD, 361                           52 Corticosteroids, 547
S. Rennard, P.J. Barnes                                P7. Barnes
Part VI: Triggers of Asthma and COPD               53 Mediator Antagonists, 565
K.F Chung, P.J. Barnes
37 Allergens, 383
D. W Cockcroft                                     54 Antibiotics, 573
S. Sharma, N. Anthonisen
38 Occupational Agents, 395
J.L. Malo, M. Chan-Yeung, S. Kennedy               55 Long-term Oxygen Therapy, 587
B.R. Celli



56 Immunomodulators, 599                                 Part IX: Clinical Management of Asthma and
C.J. Corrigan                                        COPD
57 PulmonaryVasodilators, 605                        64 Management of Chronic Asthma in Adults, 675
R.N. Channick, L.J. Rubin                            A.. Woolock
58 Ventilator Support, 611                           65 Acute Exacerbations of Asthma, 689
S. Krachman, M. Tobin                                C. Kotaru, E.R. McFadden
59 Pulmonary Rehabilitation, 617                     66 Childhood Asthma, 699
E.F.M. Wouters                                       S. Godfrey
60 Surgery, 627                                      67 Treatment for Stable COPD, 713
J. Pepper                                            S.I. Rennard
61 Other Therapies, 633                              68 Acute Exacerbations of COPD, 727
N.C. Thomson                                         J.A. Wedzicha
62 Future Therapies, 641                             69 Education and Self-Management, 737
P.J. Barnes                                          M.R. Partridge
63 Health Economics, 657                             Index, 743
S.D. Sullivan, S.A. Strassels
Colour plate section between page 56 and 57








Library of Congress subject headings for this publication: Asthma, Lungs Diseases, Obstructive